跳至主要内容
临床试验/jRCTs031240746
jRCTs031240746招募中不适用

A Randomized Clinical Trial to Compare the Efficacy and Immunogenicity of Single-Dose versus Two-Dose HPV Vaccination in Men (HPV-ONE)

未提供0 个研究点目标入组 220 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
220
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Prevention Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
18age old over 至 No limit(—)
性别
Male

入选标准

  • Male individuals aged 18 years or older at the time of consent.
  • Individuals who have provided written informed consent to participate in the study.

排除标准

  • Individuals with known allergies to the treatment medication.
  • Individuals who regularly use steroids or immunosuppressive agents.
  • Individuals with a history of receiving the 2-valent, 4-valent, or 9-valent HPV vaccine.
  • Individuals deemed unsuitable for study participation by the attending physician.

结局指标

主要结局

-

HPV16 IgG seropositivity rate at Week 96

次要结局

  • New persistent infection in the pharynx or anus(Week 48 and Week 96)
  • New cytological abnormalities(Week 48 and Week 96)
  • Histological abnormalities(Week 48 and Week 96)

研究者

发起方
未提供

相似试验